CA 19-9 can be a useful tumor marker in ovarian dermoid cysts

Clinical and Experimental Obstetrics and Gynecology

Volumn 35, Issue 2, 2008, Pages 137-139

  Coskun, A ^a   Kiran, G ^a   Ozdemir, O ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

CA 19 9 level; Dermoid cyst; Gynecological tumors

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISEASE MARKER; FEMALE; HUMAN; OVARY TERATOMA; PREOPERATIVE EVALUATION; TUMOR DIAGNOSIS; TUMOR VOLUME;

ADULT; CA-19-9 ANTIGEN; DERMOID CYST; FEMALE; HUMANS; OVARIAN NEOPLASMS;

EID: 44349171297     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kikkawa F., Nawa A., Tamakoshi K., Ishikawa H., Kuzuya K., Suganuma N. et al.: "Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary". Cancer, 1998, 82, 2249.
2. Peterson W.F., Prevost E.C., Edmunds F.T., Hundly J.M. Jr., Morris F.K.: "Benign cystic teratomas of ovary - a clinico-statistical study of 1007 cases with a review of the literature". Am. J. Obstet. Gynecol., 1955, 70, 368.
3. Magnani J.L., Nilsson B., Brockhaus M.: "A monoclonal antibodydefined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentose". J. Biol. Chem., 1982, 70, 14365.
4. Steinberg W.: "The clinical utility of the CA 19-9 tumor-associated antigen". Am. J. Gastroenterol., 1990, 85, 350.
5. Safi F., Schlosser W., Falkenreck S., Beger H.G.: "CA 19-9 serum course and prognosis of pancreatic cancer". Int. J. Pancreatol. 1996, 20, 155.
6. Kouri M., Pyrhonen S., Kuusela P.: "Elevated CA 19-9 as the most significant prognostic factor in advanced colorectal carcinoma". J. Surg. Oncol., 1992, 49, 78.
7. Lundin J., Roberts P.J., Kuusela P., Haglund C.: "The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer". Br. J. Cancer, 1994, 69, 515.
8. Nagata H., Takahashi K., Yamane Y., Yoshino K., Shibukawa T., Kitao M.: "Abnormally high values of CA 125 and CA 19-9 in women with benign tumors". Gynecol. Obstet. Invest., 1989, 28, 165.
9. Hirai K., Ishiko O., Itoh F., Nakagawa E., Kanaoka Y., Sumi T., Ogita S.: "Clinical evaluation of mature teratomas containing malignant elements". Oncol. Rep., 2000, 7, 655.
10. Kawai M., Kano T., Kikkawa F., Morikawa Y., Oguchi H., Nakashima N.: "Seven tumor markers in benign and malignant germ cell tumors of the ovary". Gynecol. Oncol., 1992, 45, 248.
11. Minami H., Itoyanagi N., Kubota F., Nakamura Y.: "A case of mediastinal mature teratoma presenting increased serum CA19-9 level". Nippon Kyobu Geka Gakkai Zasshi., 1994, 42, 2139.
12. Tsuji H., Furukawa M., Sakai A., Miyashita M., Sasaki M., Tokunaga Y et al.: "A case of mediastinal mature teratoma accompanying elevated CA 19-9 and CEA in the cystic fluid". Kyobu Geka., 2000, 53, 158.
13. Nagata K., Iwasaki Y., Nakanishi M., Natsuhara A., Harada H., Yokomura I. et al.: "A case of mediastinal teratoma with elevated serum tumor marker levels". Nihon Kokyuki Gakkai Zasshi., 2002, 40, 50.
14. Takayama T., Nonaka M., Miyazawa H., Ogawa N., Yano M., Morita T. et al.: "A case of mediastinal mature teratoma with elevated of CA 19-9 in tumor fluid". Kyobu Geka, 1991, 44, 909.
15. Ooshima M., Takahasi T., Matsumoto H., Sasaki N., Sato K., Takeda A. et al.: "Matured mediastinal teratoma with a giant cyst resembling pleural effusion on X-ray films". Nihon Kokyuki Gakkai Zasshi., 1999, 37, 509.
16. Kimura C., Kamiyoshihara M., Sakata K., Itoh H., Morishita Y.: "Mediastinal mature teratoma perforating into the lung with elevated serum carbohydrate antigen 19-9 (CA19-9) levels; report of a case". Kyobu Geka., 2003, 56, 247.
17. Sudo Y., Kobayashi M., Kako N., Iwabuchi T., Iwabuchi S., Koie H.: "Report of a case of bilateral adrenal teratoma with CA19-9 production". Nippon Geka Gakkai Zasshi., 1995, 96, 489.
18. Yoshida A., Murabayashi N., Shiozaki T., Okugawa T., Tabata T.: "Case of mature cystic teratoma of the greater omentum misdiagnosed as ovarian cyst". J. Obstet. Gynaecol. Res., 2005, 31, 399.
19. Takeshita M., Kubo O., Tajika Y., Izawa M., Kagawa M.: "Immunohistochemical detection of carbohydrate determinant 19-9 (CA 19-9) in intracranial epidermoid and dermoid cysts". Surg. Neurol., 1993, 40, 284.
20. Abe H., Sako H., Tamura Y., Tango Y., Tani T., Kodama M.: "Benign cervical teratoma in an adult: report of a case". Surg. Today., 1997, 27, 469.
21. Suzuki M., Ohwada M., Tamada T., Sakurabayashi I., Kawai T.: "Clinical evaluation of serum CA-50 and CA 19-9 in gynecological tumors". Rinsho Byori., 1989, 37, 784.
22. Dede M., Gungor S., Yenen M.C., Alanbay I., Duru N.K., Hasimi A.: "CA 19-9 may have clinical significance in mature cystic teratomas of the ovary". Int. J. Gynecol. Cancer, 2006, 16, 189.
23. Comerci J., Jr., Licciardi F., Bergh P.A., Gregori C., Breen J.L.: "Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature". Obstet. Gynecol., 1994, 84, 22.
24. Ingec M., Kadanali S., Erdogan F.: "Huge teratoma of the fallopian tube: a case report". J. Reprod. Med., 2007, 52, 247.
25. Mikuni M., Makinoda S., Tanaka T et al.: "Evaluation of tumor markers in ovarian dermoid cyst". Acta Obstet. Gynaecol. Jpn., 1990, 42, 479.
26. Ito K.: "CA19-9 in mature cystic teratoma". Tohoku J. Exp. Med., 1994, 172, 133.